Malte Peters

Malte Peters is currently Chief Executive Officer & Director at HOOKIPA Pharma, Inc. since 2024.
Since 2018, holds the positions of President, Chief Executive Officer & Director at Tango Therapeutics, Inc., Director at Tango Therapeutics Sub, Inc., Director-Cancer Research at Merck KGAA Unsponsored ADR Facility, and Research Scientist at Amgen NV.
Formerly Chief Executive Officer & Director at Hookipa Biotech AG in 2024.
Served as Director-Cancer Research at Merck KGaA from 2003 to 2004 and Medical Director at Micromet AG during the same period.
From 2004 to 2015, was Head-Clinical, Site Head-Basel & East Hanover at Novartis AG.
From 2015 to 2017, was Global Head-Clinical Development at Sandoz International GmbH.
From 2020 to 2022, was Chief Research & Development Officer at MorphoSys AG.
Education includes a doctorate from Freie Universität Berlin.